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Abstract
Background: The prevalence of prediabetes is rapidly rising in the UK, largely associated with an increase in obesity.
Lifestyle programmes that provide support to make and sustain dietary and physical activity behavioural changes are
necessary to initiate and maintain weight loss. However, these programmes are often intensive and time consuming.
Given the magnitude of the problem, there is a need for behavioural interventions that can be delivered at
scale. Digital interventions can address some of the aforementioned issues. The primary aim of the present
study is to assess the feasibility and acceptability of a digital intervention called Changing Health that provides structured
education and lifestyle behaviour change support to adults with prediabetes.
Methods: A single-group pilot study will be undertaken. We aim to recruit 40 participants with prediabetes defined by
HbA1c or fasting plasma glucose (FPG), aged between 18 and 75 years with a BMI≥ 25. Participants will receive the
digital intervention (a mobile phone app incorporating structured education and behavioural tools to support lifestyle
behaviour change) with the aim of losing and maintaining 5–6% of their baseline body weight. Each participant will
receive 100min of lifestyle coaching over the 9-month intervention period and will have continued access to the digital
intervention. Clinical outcome measures will be collected during four visits to our clinical research facility: two visits at
baseline, one visit at month 3, and one visit at month 9. These secondary outcome measures will include diet, physical
activity, sleep, metabolic control, body composition, cardiorespiratory fitness, and cardiovascular function. To measure
primary outcomes, an embedded qualitative study will be conducted to obtain data on feasibility and acceptability of
the intervention.
Discussion: This pilot study will establish whether Changing Health is feasible and acceptable to adults with prediabetes.
Clinical outcome measures will provide estimates of variability to inform sample size calculations, and qualitative data
generated will inform any necessary refinements to the intervention. This will provide a platform for a larger evaluation to
assess the effectiveness of Changing Health for changing diet and physical activity to initiate and maintain weight loss in
adults with prediabetes.
Trial registration: ISRCTN Registry: ISRCTN69270299.
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Background
The prevalence of prediabetes in the UK is rapidly rising
[1], and recent figures suggest that 12.3 million UK
adults are currently at increased risk of type 2 diabetes
[2]. Weight gain is one of the main risk factors for predi-
abetes, with obese individuals having a sevenfold in-
creased risk of developing type 2 diabetes compared to
healthy weight individuals [3]. Fortunately, these risk
factors are modifiable. There is a growing body of
evidence to demonstrate that effectively targeting diet
and physical activity reduces diabetes incidence [4], with
weight loss being the dominant predictor of diabetes risk
reduction [5].
The National Health Service (NHS) diabetes preven-
tion programme was officially launched in 2015 to
support those at high risk of type 2 diabetes to make
healthy lifestyle changes [6]. It consists of 13 education
and exercise sessions, lasting between 1 and 2 h, most of
which (at least 16 h) is delivered face-to-face by health
professionals (e.g. healthcare assistants and nurses). Des-
pite early evidence of weight loss [7] and patient uptake
[8] which has exceeded expectations, there are a number
of issues with this service. It is intensive and time
consuming to deliver and requires a substantial time
commitment from patients to attend regular face-to-face
sessions which may hinder scalability for population use
[9]. Digital interventions can offer a solution to these
issues by providing structured education and lifestyle
behaviour change support at scale, low cost [10] and
with the opportunity to integrate wearables and other
apps to maximise adherence and effectiveness [11]. The
use of digital interventions may also help to address the
issues of long waiting lists, and suboptimal engagement
and attendance rates on programmes currently delivered
face-to-face.
Although findings are mixed in terms of whether
theory-based interventions are more effective than inter-
ventions that are not theory-based or informed, support-
ing lifestyle behaviour change with theory-informed
behaviour change interventions has shown to be import-
ant for optimising long-term glycaemic control [12, 13]
and weight loss [14]. However, the availability, uptake,
and faithful delivery and receipt of such interventions in
primary care are lacking [15]. To address this issue, we
developed a multifaceted behaviour change intervention
programme to increase physical activity in adults with
type 2 diabetes called Movement as Medicine [16].
Primary care professionals (i.e. healthcare assistants,
practice nurses, and GPs) were trained to deliver a
behavioural intervention targeting increased physical
activity during routine consultations and to provide
long-term support using specific behaviour change tech-
niques delivered during face-to-face consultations.
Briefly, this intervention consisted of an online training
programme for primary healthcare professionals that
provided information content and skills-based training
to successfully deliver the patient intervention. The pa-
tient intervention included a DVD providing narratives
of the types of activity others had chosen to successfully
manage their diabetes (behaviour change technique
(BCT): providing information on the consequences of
behaviour for the individual), paper-based resources to
help facilitate a discussion about increasing activity
levels (BCT: provide feedback on performance), and
planning and monitoring resources including a pedom-
eter (BCTs: action planning, self-monitoring). Full details
of the intervention have been published previously [17].
This intervention was shown to be acceptable by health-
care professionals and patients, and feasible for delivery
during routine primary care [18]; however, qualitative
data highlighted the need for an intervention that
targeted both physical activity and diet to initiate weight
loss. It was also emphasised by healthcare professionals
that an intervention targeting patients at risk of diabetes
was required with an emphasis on weight loss. Given the
time constraints in primary care, concerns were also
raised about the time required to deliver the intervention
to all of those who require support. Furthermore, a com-
mon barrier reported by patients was the requirement to
attend face-to-face structured education sessions that
are often scheduled at inconvenient times and clash with
work and family commitments. This highlighted a need
for an alternative, scalable solution. Data generated from
the Movement as Medicine for Type 2 Diabetes trial was
therefore used to inform the development of the Chan-
ging Health intervention to address the needs identified.
Specifically, the scope of the intervention was expanded
to target both diet and physical activity behaviours with
an emphasis on weight loss. In addition, face-to-face de-
livery by primary healthcare professionals was replaced
with a digital intervention with lifestyle behaviour coach
support to address the concerns of healthcare profes-
sionals about the time taken to provide support to all
those who need it. In terms of behavioural content, the
specific behaviour change techniques incorporated in
Movement as Medicine were represented digitally within
the Changing Health app and lifestyle behaviour coaches
were trained to use these techniques during telephone
calls. The aim of this pilot study is to assess feasibility
and acceptability of the Changing Health intervention
with adults at risk of type 2 diabetes. More specifically,
the primary objectives are as follows:
1) To assess the feasibility of recruitment including
length of time required to complete participant
recruitment and retention rates (i.e. is it feasible to
recruit the number of participants required within
the specified recruitment time period)
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2) To assess acceptability of the intervention to people
with prediabetes
3) To assess adherence to and completion of the
intervention (i.e. do participants work through all
aspects of the app and take part in all coaching
sessions delivered by telephone)
4) To assess whether the intervention was delivered
and received as intended (i.e. to assess fidelity of
delivery of the intervention by recording lifestyle
behaviour coaching calls)
5) To conduct a qualitative process evaluation with
participants to identify barriers and enabling factors
to completion of the programme
The secondary objectives are to estimate the variability
in weight, physical activity, diet, sleep, metabolic control,
body composition, gut health, cardiorespiratory fitness,
and cardiovascular function, by generating interval esti-
mates of the mean difference over time for each outcome
measure. This will enable the statistical power calculations
for a subsequent larger scale evaluation to assess the
effectiveness of the intervention as part of routine clinical
care.
Methods
Study design, setting, and ethics
This is a single-group pilot study. All four study visits
will be undertaken in the Clinical Research Facility,
Royal Victoria Infirmary, The Newcastle upon Tyne
Hospitals NHS Foundation Trust, UK. The intervention
includes a mobile phone application which participants
can access in their own time and setting. Ethical ap-
proval (protocol version 7.0) was granted by Preston Re-
search Ethics Committee (17/NW/0130). NHS Research
and Development approval was granted by the Newcas-
tle upon Tyne Hospitals NHS Foundation Trust. The
study was subsequently adopted and will receive support
from the Primary Care Research Network (PCRN).
Sampling and recruitment
A sample size of N = 40 was agreed in accordance with
published guidance for pilot studies and allows for drop-
outs [19]. Local primary care practices will be recruited
through the North East and North Cumbria Clinical Re-
search Network who help identify and approach partici-
pant identification centres (PICs). Those interested will
be recruited on a first come first serve basis. Recruit-
ment of participants will be facilitated by recruited
primary care practices who will mail out invitations to
patients meeting the study eligibility criteria (Table 1).
These patients will be asked to contact a member of the
study team if they are interested in taking part. During
an initial screening visit, written informed consent will
be obtained by a member of the study team. This will
then be followed by a complete medical history, full body
examination, and other clinical measures (see Table 2)
which will determine if the patient is eligible to take part.
Inclusion/exclusion criteria
The inclusion and exclusion criteria can be seen in
Table 1. An HbA1c of 5.7–6.4% (39–47mmol/mol) and/
or fasting plasma glucose (FPG) of 5.6–6.9 mmol/L from
primary care records will be used for diagnosis of predia-
betes and type 2 diabetes. HbA1c does not necessitate
fasting; therefore, it is the most practical measure to use
when recruiting from GP practices. A HbA1c in the
required range taken in the past 12 months will be used,
or FPG if this is the only measure available from medical
records. As part of the clinical testing (four visits to the
lab), a number of blood tests will be performed. We
therefore expect discrepancies between our blood results
and those recorded in primary care, due to different
testing methods and inherent biological variability. An
update from the NHS DPP has highlighted a number of
issues which may arise [20], and these will be resolved as
described below:
1. Discrepancy between referral test result and
screening results. The result from referral should be
used to determine entry into the study. If the
screening visit result suggests an individual has
moved into the type 2 diabetes range, they will be
Table 1 Patient eligibility criteria
Inclusion criteria
• Prediabetes based on primary care record of HbA1c 5.7–6.4% (39–
47 mmol/mol) and/or FPG 5.6–6.9 mmol/L, in the past 12 months (see
above for discrepancies between blood results)
• No previous diagnosis of type 2 diabetes
• Age≥ 18–75 years
• BMI≥ 25 kg/m2
• Weight stable for the past 6 months
• Access to and able to use a smart mobile phone
• Willing and able to provide written informed consent
• Willing to undertake study activities
Exclusion criteria
• Inability to speak or read English without the assistance of an
interpreter
• Contraindications to exercise determined during exercise screening
• Contraindications to weight loss
• Mental or physical incapacity which makes self-management
inappropriate
• Pregnancy, planning pregnancy, or lactating
• Unable to meaningfully participate for the full duration of the study
• Participated in an intervention research study within the last 6
months
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referred back to their GP. If the patients’ HbA1c is
≥ 52mmol/mol, they will not be considered eligible.
Those with a value between 48 and 51 mmol/mol
can elect to remain in the study, due to the
variability around the HbA1c measurement.
2. Inconsistent results from HbA1c and FPG on
referral. If either reading is in the type 2 diabetes
range, patients will not be eligible for inclusion.
Intervention
Each participant will receive an email with instructions
on how to access the app. Once this email is sent, the
time taken for the participant to login will be monitored.
In the instance where the app has not been accessed
within a week of the email being sent, a lifestyle behav-
iour coach will contact the participant to ask if they
require support to login and use the app. Participants
will have continuous access to the Changing Health
intervention for a period of 9 months. The intervention
includes a mobile phone app with lifestyle behaviour
coach support delivered by telephone. Participants will
be supported to lose 5–6% of their baseline body weight
over a 9-month time period. In a situation where partici-
pants achieve this target earlier, they will be supported
to either (i) maintain weight loss or (ii) continue to lose
weight should they wish. The mobile phone app pro-
vides structured education on a number of topics (see
Table 3) delivered using a range of formats including
animations, illustrated articles, and interactive features.
Participants will be required to complete the structured
education content before they are given access to a
lifestyle behaviour coach. Coaching appointments can be
pre-booked using a live calendar function linked to each
coach’s availability. In addition to the structured education
content, the app contains a range of behavioural features
that enable participants to set goals, plan, and monitor
their progress. For example, diet can be monitored using a
photo diary via the camera of the smartphone, and daily
physical activity levels can be monitored using the smart-
phone’s built-in step counting function. Lifestyle behav-
iour coaches will support participants to set realistic and
meaningful dietary and physical activity goals, and they
will be encouraged to log their weight on a weekly basis.
The intervention is underpinned by the Health Action
Process Approach [21] and incorporates a range of behav-
iour change techniques (e.g. information about health
consequences, goal setting behaviour, goal setting out-
comes, self-monitoring outcomes of behaviour) in accord-
ance with the behaviour change technique (BCT)
taxonomy V1 [21] to facilitate operationalisation of the
behavioural constructs of the model (see Table 3 for a
summary of behaviour change techniques of the interven-
tion). The lifestyle behaviour coach will have access to all
data recorded by each participant (e.g. goals, plans, and
self-monitoring data) and will use this to inform the struc-
ture and delivery of each telephone coaching appointment.
The coach will be able to view progress and will offer up
to 1 × 20min (first telephone call) and subsequent calls of
8 × 10min over the duration of the programme. Partici-
pants will be able to choose the frequency of lifestyle
coaching appointments up to a maximum of 100min.
Lifestyle behaviour coaches are individuals with qualifica-
tions in health psychology, sports and exercise science,
nutrition, or public health and/or who have experience of
working with people to support lifestyle behaviour change.
They were recruited by Changing Health Ltd. on this
basis, and each has received training delivered by a Char-
tered Health Psychologist with expertise in health behav-
iour change. Training was delivered face-to-face in a
group setting over four consecutive days and covered
information topics such as ‘what is prediabetes’ and ‘the
use of diet and physical activity to prevent type 2 diabetes’,
and focussed on the use of brief motivational techniques
and delivery of behaviour change techniques in accord-
ance with the content and underpinning theory of the
intervention. A series of role play activities were under-
taken to practice delivery of the intervention, and feedback
was provided on performance.
Primary outcomes
A mixed methods approach will be adopted to establish
feasibility and acceptability. As such, we will collect data
on feasibility and acceptability as outlined below.
Table 2 Schedule of enrolment and assessments
Study phase Baseline 1
(screening)
(month 0)
Baseline
2 (month
0)
Mid visit
(month
3)
End visit
(month
9)
Week − 1 0 13 37
Visit number 1 2 3 4
Inclusion/exclusion
criteria
X X X X
Informed consent X
Medical history X
Physical examination X X X
Exercise stress test/
cardiac and vascular
function
X X X
Intake 24 X X X
Physical activity X X X
Stool/urine sample X X X
Fasting blood sample X X X
Oral glucose tolerance
test
X X X
Skin swab X X X
Body composition/
waist:hip
X X X
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Feasibility
Feasibility will be assessed by collecting data on the
following:
– Recruitment and retention rates
– Adherence rates
– Time required to recruit to target
– Number of eligible participants required to recruit
required sample size
– Rate of completion of the intervention (i.e. number
of participants who access and complete all aspects
of the intervention including lifestyle coach support)
Table 3 Modules within the education content of the app
Module Purpose Videos (V) + articles (A) Behaviour change
techniques incorporated
Understanding
diabetes
• Explaining how type 2 diabetes affects the body
• Making clear which risk factors are modifiable
• Dispelling diabetes myths
• Making clear that change is possible
V1—What is type 2 diabetes
A1—What is prediabetes
A2—Risk factors for diabetes
A3—The role of your genes in
diabetes risk
V2—Managing your risk of type 2
diabetes
A4—Understanding your test
results
A5—Why do not all bigger people
get type 2 diabetes
• Information about health
consequences
Steps to
success
• Introducing the most important behaviour change techniques
for risk modification
• Providing a framework for successful lifestyle change
• Introducing the concept of lifestyle coaching
• Providing motivation to continue with the learning programme
in order to gain access to a lifestyle coach
V1—Maximising your chance of
success
A1—Five essential tips to goal
setting
A2—Using ‘self-talk’
A3—Getting started with coaching
• Goal setting (behaviour)
• Goal setting (outcome)
• Self-monitoring of out-
comes of behaviour
• Action planning
• Social support
(unspecified)
• Barrier identification
• Time management
• Self-talk
• Feedback on behaviour
• Review behaviour goals
• Follow-up prompts
Understanding
food
• Breaking down the food we eat into its component parts
• Explaining how each of those parts affects glucose control
A1—Eating to feel full
A2—Understanding fat in your diet
V1—How eating affects your
weight
V2—Carbs in your diet
A3—How big is ‘a portion’?
A4—Top ten food myths
• Information about health
consequences
Changing your
diet
• Overview of three eating approaches that have been proven to
be effective for improving glucose control
• Interactive tools to support dietary change
V1—Finding the right diet for you
V2—Low carb approach
V3—Intermittent fasting
V4—Mediterranean diet
V5—Supermarket tour
A1—Using prompts and cues
A2—Recipe ideas for the low carb
diet approach
A3—More about the low carb diet
approach
A4—More about the Mediterranean
diet
A5—More about intermittent
fasting
• Information about health
consequences
• Prompts/cues
Getting active • The role of physical activity in weight loss and glucose control
• Testing knowledge of activity recommendations
• Introducing types of activity most effective for weight loss and
improved glucose control
V1—How our changing lifestyles
contribute to weight gain
V2—Combining exercise and diet
A1—Why combining works best
A2—Aerobic and resistance fitness
A3—Could HIIT be the right fit?
A4—The benefits of resistance
exercise
Plugin: Set an activity goal
• Self-monitoring of
behaviour
• Information about health
consequences
• Provide instruction
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– Feasibility of testing procedures and data collection
methods, including completion rates
Fidelity assessment
All lifestyle behaviour coach telephone calls will be audio
recorded throughout the intervention period to facilitate
fidelity of delivery assessment (i.e. to determine whether
it is feasible to deliver the intervention as intended). Re-
cordings will be independently coded by two members
of the research team using a checklist of intervention
content. Inter-rater reliability will be assessed between
coders using Krippendorff’s alpha [22]. We will also
collect data on the number of times the mobile phone
app is accessed by each participant and areas of the app
most frequently accessed.
Acceptability
Acceptability of the intervention and study procedures
will be assessed both quantitatively and qualitatively.
Quantitative data will be collected to investigate (i) the
number of times participants login to the app to access
the education content and behavioural tools, and over
what time period (i.e. whether access is within a discrete
period of time or over the entire intervention period),
and (ii) whether participants make an initial and subse-
quent lifestyle behaviour coach appointments over the
duration of the intervention. An embedded qualitative
study will obtain patients’ views and experiences of the
intervention, including what they perceive to be barriers
and facilitators to using it. In accordance with published
guidance and similar research we have conducted [18,
23], and to allow for data saturation, at least 10 and up
to 16 participants will be interviewed [24]. Topic guides
will be used to conduct interviews (see Additional file 1
for an example topic guide). We will also record the
uptake of lifestyle coaching to make an assessment of
acceptability of the service.
Secondary outcomes
Although this study is not powered to detect clinically
significant changes in weight and clinical outcome mea-
sures, we will collect these data on each outcome
respectively to generate interval estimates of the change
and to also determine whether the testing components
that would be used in a larger evaluation are feasible.
Participants will be asked to attend the Clinical Re-
search Facility on four separate visits: two visits at base-
line, one visit at month 3, and one visit at month 9.
There are two baseline visits to prevent participants
attending one prolonged visit. A number of physiological
variables will be measured across the four visits (see
Table 2), in the following categories:
1. Metabolic control, weight, and body composition. A
75-g oral glucose tolerance test will be performed,
and plasma glucose and insulin will be measured
over a 2-h period, so that insulin resistance and beta
cell function, and area under the glucose curve can
be predicted. Fasting plasma samples will be
analysed for alanine phosphatase, alanine
transaminase, aspartate aminotransferase, total
cholesterol, triacylglycerols, and HbA1c. Weight
and body composition will be measured using air
displacement plethysmography (BodPod, Life
Measurement, CA, USA).
2. Cardiorespiratory fitness. A medical history, physical
examination, and 12-lead electrocardiogram will be
performed prior to a maximal cardiopulmonary
exercise test. The test will include a ramped
exercise protocol using an electronically braked
semi-recumbent cycle ergometer (Corival Lode,
Groningen, The Netherlands) and gas exchange to
measure peak oxygen consumption (VO2peak).
3. Cardiovascular function. Cardiac and vascular
parameters will be assessed at rest (for 20 min) and
during cardiopulmonary exercise testing using non-
invasive methods for cardiac output, heart rate and
blood pressure variability (TaskForce and Smart
Cardia), and arterial stiffness (SphygmoCor).
4. Physical activity, sleep + diet. Physical activity and
sleep will be measured using a 7-day accelerometer
worn on the wrist (GeneActiv). Dietary patterns will
be collected using Intake24 (https://intake24.co.uk/)
which is a validated dietary recall method of dietary
assessment, which requires individuals to input
their food intake with accurate image-based portion
size estimation over 3 days.
5. Other. Participants will be asked to provide a stool
and urine sample for microbiome and metabolomic
analysis for the assessment of bacterial flora and
metabolites present in urine. A simple skin swab
that assesses skin damage and tests for
mitochondrial (mDNA) dysfunction will be
performed.
Criteria to proceed to a larger evaluation
A decision to proceed to a larger scale evaluation will be
based on recruitment, retention, outcome data generated
(amount of data obtained and the outcome of the data
obtained), intervention acceptability and feasibility, and
fidelity of delivery [25]. If we fail to recruit 80% of the
target sample size, screening logs will be assessed to deter-
mine whether insufficient participants were approached/
screened, whether insufficient participants met eligibility
criteria, and from those eligible, whether they subse-
quently agreed to participate. Based on these findings, we
will establish whether to proceed with a larger evaluation
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if the intervention was found to be both feasible to deliver
and acceptable to participants following minor modifica-
tion if required. Outcome data for at least 80% of partici-
pants at the 9-month time point will be required to help
inform our decision on whether we should proceed to a
larger trial (i.e. whether it is feasible to collect the data
required and findings from the data once analysed).
Analysis
Quantitative data analysis
Data from this pilot study will be descriptive with out-
comes being interval estimates of variables relating to
feasibility and acceptability. As this is a pilot study, the
level of missing data will be documented but no imput-
ation will be undertaken.
Qualitative data analysis
All interviews will be audio recorded and transcribed
verbatim. Transcripts will be analysed using the Theor-
etical Domains Framework (TDF) [26]. The TDF was
developed to simplify and integrate 33 behaviour change
theories and 128 key theoretical constructs related to
behaviour change. These were synthesised into a single
framework to allow an assessment of behaviours. The
TDF originally comprised of 12 domains, which was
subsequently validated and refined to 14 domains. These
are knowledge; skills; social/professional role and iden-
tity; beliefs about capabilities; optimism; beliefs about
consequences; reinforcement; intentions; goals; memory,
attention, and decision processes; environmental context
and resources; social influences; emotion; and behav-
ioural regulation. The 14 domain framework will be used
for the purpose of this study.
A two-stage process will be followed in order to ana-
lyse interview transcripts. The first interview transcript
will be pilot-coded independently by two researchers to
agree a coding strategy (i.e. to ensure both researchers
are coding consistently and to discuss and resolve any
difficulties when applying the TDF). Initial findings of
the pilot transcript will be discussed before coding the
remaining transcripts. Secondly, data from the remaining
transcripts will be independently coded by the same two
researchers. This will involve reading and re-reading
transcripts, coding the content into themes and sub-
themes, and mapping these, with supporting direct quotes,
to an appropriate theoretical domain of the TDF.
Discussion
Providing patients with structured education and life-
style behaviour change support is essential to help pre-
vent the onset of type 2 diabetes in those at risk [4].
Digital technology provides a means of delivering educa-
tion and long-term lifestyle behaviour change support at
scale and at a lower unit cost. Recent evidence suggests
that behaviour change interventions provided through
brief remote support can be effective for weight loss
[27]. This study aims to assess feasibility and acceptabil-
ity of the behavioural intervention Changing Health that
targets diet and physical activity behaviours to initiate
weight loss and support long-term weight loss mainten-
ance in adults with prediabetes.
Targeting lifestyle behaviour has shown to lead to
weight loss and a reduction in diabetes incidence [4].
The Changing Health intervention is underpinned by
theory (Health Action Process Approach) and was sys-
tematically developed, informed by research evidence
[12, 13, 16] to operationalise the constructs of the theory
using specific behaviour change techniques. These tech-
niques target motivation to support intention formation
and volition to support enactment and maintenance of
behaviour change. Lifestyle behaviour coaches are an im-
portant intervention feature/component to support
meaningful and realistic goal setting, action planning,
and coping planning and to facilitate adherence to the
digital intervention. A mixed methods design will enable
us to identify (i) whether lifestyle coaches can deliver
intervention components as intended, and if so whether
faithful delivery of these components leads to a change
in lifestyle behaviours (diet and physical activity behav-
iour), and (ii) to determine whether the intervention
components are acceptable to individuals with prediabe-
tes. We will also assess whether recruitment to target is
feasible and whether patients are willing to complete the
intervention.
Weight loss is key to prevent type 2 diabetes; however,
estimates suggest that only 20% of overweight individuals
are successful at long-term weight loss [9]. Although the
study is not powered to detect changes in weight and
other clinical outcomes, we will measure these to provide
calculations to inform a larger evaluation. We will explore
the potential impact of the intervention on cardiorespira-
tory fitness, which is strongly linked to mortality and has
also been shown to predict individual response to lifestyle
intervention. The impact on metabolic control, cardiovas-
cular function, and gut health will also be explored as
weight loss leads to improvements in such variables [28].
The results from this pilot study will help to explore
whether this digital intervention (Changing Health) in-
volving structured education and lifestyle behaviour
coach support is feasible and acceptable for adults with
prediabetes. This will lay the foundations for a larger
evaluation to determine whether this intervention is ef-
fective at scale for long-term weight loss and preventing
type 2 diabetes in those at risk.
Trial status
Recruitment will begin on July 2018 and be completed
on December 2019. Protocol v7.0, 15 March 2018.
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Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s40814-019-0519-1.
Additional file 1. Interview questions.
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